Metronidazole: A Comprehensive Overview

Metronidazole is a synthetic nitroimidazole antibiotic and antiprotozoal agent widely used in clinical medicine. First introduced in the 1960s for the treatment of trichomoniasis, its spectrum of activity has since expanded to include a variety of anaerobic bacteria and certain parasitic infections. This report provides a concise review of its pharmacology, mechanisms of action, clinical indications, adverse effects, drug interactions, and resistance considerations.



Mechanism of Action and Pharmacology
Metronidazole exerts its antimicrobial effects through a unique mechanism that requires reductive activation within susceptible microorganisms. The drug enters bacterial or protozoal cells by passive diffusion. In anaerobic environments, the nitro group of metronidazole is reduced by ferredoxin or flavodoxin redox systems present in these organisms. The resulting reduced metabolites (e.g., hydroxylamine derivatives) are cytotoxic and cause DNA strand breakage, leading to cell death. This selective toxicity explains why metronidazole is effective against obligate anaerobes but not aerobic bacteria, as oxygen prevents the necessary reduction. Metronidazole is also active against some microaerophilic organisms such as Helicobacter pylori and Gardnerella vaginalis.



Pharmacokinetically, metronidazole is well absorbed after oral administration, with bioavailability exceeding 80%. It distributes widely into tissues, including cerebrospinal fluid, and reaches therapeutic concentrations in bone, Rumalaya gel: Alivio Clínico del Dolor Articular — Revisión 2024 abscess cavities, and the central nervous system. Approximately 20% of the drug is protein-bound. Hepatic metabolism occurs primarily via oxidation to inactive metabolites, and renal excretion accounts for about 60–80% of the dose. The elimination half-life is around 8 hours, which may be prolonged in patients with hepatic impairment.



Clinical Indications
Metronidazole is indicated for a broad range of infections:

Anaerobic bacterial infections: It is a cornerstone in the treatment of intra-abdominal infections (e.g., peritonitis, appendicitis), pelvic infections (e.g., endometritis, tubo-ovarian abscess), and skin and soft tissue infections caused by Bacteroides fragilis, Clostridium species, and other anaerobes. It is often combined with other antibiotics (e.g., ceftriaxone, gentamicin) to cover both aerobic and anaerobic pathogens.
Protozoal infections: Metronidazole is first-line therapy for trichomoniasis, giardiasis, and amebiasis (including amebic dysentery and liver abscess). It is also effective against balantidiasis.
Helicobacter pylori eradication: As part of combination regimens (e.g., with a proton pump inhibitor and clarithromycin or amoxicillin), metronidazole helps treat peptic ulcer disease caused by H. pylori.
Clostridioides difficile infection: Although oral vancomycin is often preferred for severe cases, metronidazole remains a recommended option for mild to moderate C. difficile infection.
Other uses: It is used for bacterial vaginosis (usually intravaginal or oral), periodontal infections, and as a prophylactic agent in colorectal surgery. Additionally, metronidazole has been employed off-label for cutaneous rosacea (topical) and for treatment of brain abscesses.

Adverse Effects

Metronidazole is generally well-tolerated, but adverse effects can occur. Common gastrointestinal side effects include nausea, vomiting, metallic taste (dysgeusia), and anorexia. Neurological effects are less common but notable: peripheral neuropathy (usually reversible), headache, and dizziness. High doses or prolonged use may rarely cause seizures or encephalopathy. Other effects include reversible neutropenia, urinary tract discoloration (dark urine due to metabolites), and disulfiram-like reactions when combined with alcohol. Topical formulations may cause local itching or burning. Hypersensitivity reactions are rare.



Drug Interactions
Metronidazole inhibits hepatic CYP450 enzymes, particularly CYP2C9, leading to increased serum levels of warfarin and enhanced anticoagulant effect. Concomitant use with alcohol or propylene glycol-containing products can cause severe nausea, vomiting, flushing, and abdominal cramps (disulfiram-like reaction). Cimetidine may reduce metronidazole clearance, while phenytoin and phenobarbital may accelerate its metabolism. Patients taking lithium should be monitored due to possible increased lithium toxicity.



Resistance and Considerations
Resistance to metronidazole is less common than with many antibiotics, but it has been documented, especially in Bacteroides fragilis, H. pylori, and Giardia intestinalis. Mechanisms include reduced drug uptake, increased efflux, impaired reductive activation (e.g., mutation in ferredoxin or nitroreductase genes), and inactivation of the drug. Rates vary geographically. To minimize resistance, metronidazole should be used judiciously and in appropriate combinations, particularly for H. pylori eradication.



Special Populations
In pregnancy, metronidazole is generally avoided in the first trimester due to theoretical teratogenicity (though large studies have not confirmed significant risk). It is considered safe for use after the first trimester and is a first-line agent for trichomoniasis in pregnant women. It is excreted in breast milk, so caution is advised during lactation. Dose adjustment is not typically required for renal impairment, but reduction is recommended for severe hepatic impairment (e.g., Child-Pugh class C). Pediatric dosing is weight-based.



Conclusion
Metronidazole remains an essential antibiotic and antiprotozoal agent with a well-defined niche in treating anaerobic infections and parasitic diseases. Its favorable pharmacokinetics, oral and intravenous availability, and low cost contribute to its widespread use. Clinicians must be aware of its drug interactions, especially with alcohol and warfarin, and monitor for rare neurological adverse effects. Continued surveillance for resistance is warranted, but metronidazole’s unique mechanism of action ensures its ongoing value in modern therapeutics.